DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Primaxin I.V. (Imipenem / Cilastatin Sodium) - Published Studies

 
 



Primaxin I.V. Related Published Studies

Well-designed clinical trials related to Primaxin I.V. (Imipenem / Cilastatin)

Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation. [2010.11]

Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. [2010.07.21]

Population Pharmacokinetics and Pharmacodynamics of Continuous vs. Short-Term Infusion of Imipenem/Cilastatin in Critically Ill Patients: A Randomized, Controlled Trial. [2007.07.09]

Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia. [2006]

Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study. [2005.09]

Pharmacokinetics of imipenem-cilastatin following intravenous administration in healthy adult horses. [2005.08]

Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis. [2005]

Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis--a randomized controlled trial. [2004.09]

Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients. [2004.08]

Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection. [2004.07]

A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies. [2004]

Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study. [2003.11]

Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin. [2003.11]

Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study. [2003.02]

A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections. [2002.12]

Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections. [2002.02]

Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections. [2001.11]

[A randomized, controlled clinical trial of meropenem and imipenem/cilastatin in the treatment of acute bacterial infections] [2001.09]

[Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)] [2001.05.05]

An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia. [2001.03]

Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. [2001.01]

Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin. [2000.12]

Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit. [2000.06]

Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients. [2000.05]

Cost-effectiveness study of imipenem/cilastatin versus meropenem in intra-abdominal infections. [2000]

Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial. [1999.12]

Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections. [1999.11]

Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis. [1999.09]

Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients. [1999.07]

Treatment of complicated intra-abdominal infections: comparison of the tolerability and safety of intravenous/oral trovafloxacin versus intravenous imipenem/cilastatin switching to oral amoxycillin/clavulanic acid. [1999.04]

Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia. [1999.03]

Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections. [1999.02]

Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: a Canadian hospital perspective. [1999.02]

Ticarcillin/clavulanate versus imipenem/cilistatin for the treatment of infections associated with gangrenous and perforated appendicitis. [1999.02]

Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia. [1999]

Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group. [1998.12]

Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis. [1998.11]

[Comparative study of the cost-effectiveness of initial therapy with imipenem/cilastatin in secondary peritonitis] [1998.10]

Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer). [1998.10]

Treatment of obstetric and gynecologic infections with meropenem: comparison with imipenem/cilastatin. [1998.04]

A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group. [1997.12]

Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections. [1997.11]

Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients. [1997.04]

[Meropenem (Merrem) vs imipenem/cilastatin in hospital treatment of intra-abdominal infections. A multicenter study] [1997.03]

Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. [1997.01]

Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial. [1997]

Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime. [1997]

[Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders] [1996.12]

Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients. [1996.11]

Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group. [1996.09]

Pharmacokinetics of aztreonam and imipenem in critically ill patients with pneumonia. [1996.09]

[Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study] [1996.04]

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group. [1996.03]

Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin. [1996.01]

A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections. [1996]

Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group. [1996]

[Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract] [1995.09]

Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Meropenem Study Group. [1995.07]

Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group. [1995.07]

A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. [1995.07]

Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections. [1995.04]

[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients] [1995.03]

Pharmacoeconomics of piperacillin/tazobactam and imipenem/cilastatin in the treatment of patients with intra-abdominal infections. [1995.01]

Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections. [1995.01]

Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever. [1994.11]

A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients. [1994.10]

[A comparative study of imipenem/cilastatin sodium BID vs QID in the treatment of infections associated with hematopoietic disorders] [1994.10]

[Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections] [1994.09]

Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. [1994.05]

Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections. [1993.09]

Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group. [1993.06]

Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery. [1993.06]

Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections. [1993.03]

A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group. [1993.01]

Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections. [1993]

[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin] [1992.10]

[A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases] [1992.08]

Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections. [1992.06]

[Short-term perioperative antibacterial prophylaxis using imipenem-cilastatin versus acylureide penicillins in pacemaker implantation. A 30-month follow-up] [1992.05]

Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients. [1992.04]

Efficacy and tolerability of imipenem-cilastatin versus clindamycin+gentamicin for serious pelvic infections. [1992.01]

Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin+aminoglycoside combination therapy for treatment of serious lower respiratory, intra-abdominal, gynecologic, and urinary tract infections. [1992.01]

Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis. [1992]

Single dose imipenem-cilastatin compared with three doses of cefuroxime and metronidazole as prophylaxis in elective colorectal surgery: a prospective randomized study. [1991.12]

A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer. [1991.12]

Imipenem/cilastatin as empirical treatment of severe infections in compromised patients. [1991.01]

Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. [1990.11]

Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients. [1990.07]

[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units] [1990.04.04]

The efficacy and safety of imipenem/cilastatin in the treatment of severe bacterial infections. [1990.04]

Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias. [1990.04]

A comparison between imipenem and metronidazole prophylaxis against sepsis following appendicectomy. [1990.04]

Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101. [1990.03]

A comparative study of ceftriaxone plus amikacin, ceftazidime plus amikacin and imipenem/cilastatin in the empiric therapy of febrile granulocytopenic cancer patients. [1989]

Ceftriaxone versus imipenem/cilastatin as empirical monotherapy for infections in cancer patients. [1989]

Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients. [1988.07.25]

Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis. [1988.04]

Randomized trial of imipenem-cilastatin versus gentamicin plus clindamycin in the treatment of polymicrobial infections. [1988]

Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections. [1987.10]

Imipenem/cilastatin versus aminoglycoside plus amoxicillin plus clindamycin in the treatment of serious postoperative infections. [1987]

Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study. [1987]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017